Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
4/22/2025
China Approves New Indication of Opdivo for NSCLC
4/22/2025
AZ's Ultomiris for Generalized Myasthenia Gravis in China
4/22/2025
China Seeks Feedback on ICH Draft Guideline M13B for Biowaivers of Add...
4/22/2025
Fosun Boosts Stake in Henlius After Failed Privatization Attempt
4/22/2025
Fujifilm Capitalizes on U.S.-China Tensions with $3B Biopharma Deal
4/22/2025
Carbogen Amcis Secures Chinese Drug Manufacturing License
4/22/2025
China Broadens Healthcare Access: Foreign Doctors and Drug Import Refo...
4/19/2025
Akeso's Ebdarokimab Approved in China as First Domestic IL-12/IL-23 An...
4/19/2025
Haleon Achieves Full Ownership of Tianjin SmithKline JV
4/19/2025
China Issues New Guidelines to Streamline Mainland Registration for Or...
4/18/2025
WuXi Biologics Completes 15,000L PPQ at Hangzhou Site
4/18/2025
Chinese drugmakers weigh options as US mulls pharma tariffs (KrAsia)
4/17/2025
Interpretation of the Anti-Monopoly Guidelines for Pharmaceutical Sect...
4/17/2025
BMS Launches Head-to-Head Phase 1 Trial for SystImmune-Licensed EGFR/H...
4/17/2025
Eli Lilly's Mirikizumab Advances in China with New Indication Filing
4/17/2025
Sanofi Secures Global Rights to AI-Discovered BsAb in $1.8B+ Deal with...
4/17/2025
Eddingpharm to Take Over Genor in HKEX's First 18A Reverse Merger
4/17/2025
WuXi AppTec Cashes Out of WuXi XDC as U.S. Tariff Threats Mount
4/17/2025
Pharma Giants Already Moving to Cut Reliance on China Amid Tariff Unce...
4/15/2025
Gardasil9 Gains Expanded Approval in China
4/15/2025
China NMPA Approves Kowa's Parmodia (Pemafibrate) for Dyslipidemia Tre...
4/15/2025
Chinese Pharma Companies Rethink Global Strategies as US Considers Dru...
4/14/2025
Sirius Receives FDA IND Clearance for FIC siRNA Therapy SRSD216 Target...
4/14/2025
Belief BioMed/Takeda's hemophilia B Gene Therapy BBM-H901 Approved in...
4/14/2025
Trump vs China Biotech: Who Will Emerge Victorious in the Tariff Trade...
4/14/2025
China's Online Pharmacy Market Surpasses CNY 70B: WMs Gain Ground as D...
4/11/2025
China Greenlights First Gene Therapy for Hemophilia B
4/11/2025
YiChang HEC ChangJiang Privatization Advances with NDRC Approval, Fina...
4/11/2025
Eli Lilly Seeks Approval for Novel Breast Cancer Drug in China, Target...
4/11/2025
Recent Executive Moves
Page:
2
/
356
Total number of articles:
10655
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit